Citation Tools

Download PDFPDF

Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations

Download to a citation manager

Cite this article as:
Gong J, Chehrazi-Raffle A, Reddi S, et al
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations